Title : Characterization of CYP26B1-Selective Inhibitor, DX314, as a Potential Therapeutic for Keratinization Disorders.

Pub. Date : 2021 Jan

PMID : 32505549






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Substrate-based inhibitor DX314 has enhanced selectivity for RA-metabolizing enzyme CYP26B1 and may offer an improved treatment option for keratinization disorders such as congenital ichthyosis and Darier disease. Tretinoin cytochrome P450 family 26 subfamily B member 1 Homo sapiens